
New Agrarian is an investment vehicle focused exclusively on cellular agriculture, encompassing cultivated meat, fermentation, and enabling technologies. Founded by billionaire Jim Mellon, it invests in, develops, and manages modern clean food companies that combat food insecurity through advanced biomanufacturing processes.
33% of their portfolio is in Biotech & Life Sciences. They made 3 investments in the last 12 months. Their most common stage is series-a (53% of deals). Average disclosed round size is $44.0M (across 13 rounds with reported amounts).
Portfolio
12
Fund Size
—
Top Stage
Series A
Last 12 Mo
3
Team
Jim Mellon
British entrepreneur, author, and founding investor in numerous biotech and agritech companies.
Denham Eke
Denham Eke began his career in stockbroking before moving into corporate planning for a major UK insurance broker.
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Series D | $55M | Nov 2025 | |
| Series D | — | Nov 2025 | |
| Series D | $55M | Nov 2025 | |
| Bridge | $50.5M | Jan 2025 | |
| Seed | $125M | Jan 2025 | |
| Series A | $22.5M | Sep 2024 | |
| VVitroLabs Inc | Series A | $46M | May 2022 |
| Series A | $46M | May 2022 | |
| Series A | $25M | Jan 2022 | |
| Series A | — | Jan 2022 | |
| Seed | $3M | Jan 2018 | |
| Series A | $50.5M | — | |
| Series A | $37.5M | — | |
| LLiberation Bioindustries | Debt | $50.5M | — |
| Series A | $6M | — |
Top Co-Investors
Last updated: 20 October 2026